Acceleron Pharma Appoints Terrence C. Kearney To Its Board Of Directors
7/14/2014 10:30:48 AM
Acceleron Pharma Inc. (NASDAQ:XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced the appointment of Terrence C. Kearney to its Board of Directors and to the position of Chair of the Audit Committee.
Help employers find you! Check out all the jobs and post your resume.
comments powered by